Cargando…
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
A proportion of people infected with SARS-CoV-2 develop moderate or severe COVID-19, with an increased risk of thromboembolic complications. The inflammatory response to SARS-CoV-2 infection can cause an acute-phase response and endothelial dysfunction, which contribute to COVID-19-associated coagul...
Autores principales: | Vincent, Jean-Louis, Levi, Marcel, Hunt, Beverley J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616572/ https://www.ncbi.nlm.nih.gov/pubmed/34838161 http://dx.doi.org/10.1016/S2213-2600(21)00455-0 |
Ejemplares similares
-
Thrombosis and coagulopathy in COVID‐19: An illustrated review
por: Levi, Marcel, et al.
Publicado: (2020) -
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients
por: Convertino, Irma, et al.
Publicado: (2020) -
Positioning Digital Tracing Applications in the Management of the COVID-19 Pandemic in France
por: Albouy-Llaty, Marion, et al.
Publicado: (2021) -
Sleep deprivation and starvation in hospitalised patients: how medical care can harm patients
por: Xu, Tim, et al.
Publicado: (2016) -
The paradox of ventilator-associated pneumonia prevention measures
por: Klompas, Michael
Publicado: (2009)